{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:30:13Z","timestamp":1754163013134,"version":"3.41.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00952-5","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T22:48:52Z","timestamp":1733698132000},"page":"527-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Takayasu arteritis-associated refractory hypertension induces nephrotic syndrome through glomerular microangiopathy"],"prefix":"10.1007","volume":"14","author":[{"given":"Tomoya","family":"Nakayamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-1809","authenticated-orcid":false,"given":"Kensei","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikei","family":"Natori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"issue":"1","key":"952_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33890","volume":"15","author":"A Juarez","year":"2023","unstructured":"Juarez A, Galindo L, Gondal M. Hypertension-induced thrombotic microangiopathy leading to end-stage renal disease. Cureus. 2023;15(1): e33890. https:\/\/doi.org\/10.7759\/cureus.33890.","journal-title":"Cureus"},{"issue":"18","key":"952_CR2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/circulationaha.114.012547","volume":"132","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with takayasu arteritis observed from cross-country research in japan: age and sex specificity. Circulation. 2015;132(18):1701\u20139. https:\/\/doi.org\/10.1161\/circulationaha.114.012547.","journal-title":"Circulation"},{"issue":"5","key":"952_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","volume":"81","author":"DS Genest","year":"2023","unstructured":"Genest DS, Patriquin CJ, Licht C, John R, Reich HN. Renal thrombotic microangiopathy: a review. Am J Kidney Dis. 2023;81(5):591\u2013605. https:\/\/doi.org\/10.1053\/j.ajkd.2022.10.014.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"952_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"952_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/acr.24632","volume":"73","author":"M Maz","year":"2021","unstructured":"Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis Care Res (Hoboken). 2021;73(8):1071\u201387. https:\/\/doi.org\/10.1002\/acr.24632.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"952_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/01.cir.80.3.429","volume":"80","author":"R Subramanyan","year":"1989","unstructured":"Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu\u2019s disease). Circulation. 1989;80(3):429\u201337. https:\/\/doi.org\/10.1161\/01.cir.80.3.429.","journal-title":"Circulation"},{"issue":"7","key":"952_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s2213-8587(18)30100-1","volume":"6","author":"M Packer","year":"2018","unstructured":"Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, et al. Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. Lancet Diabetes Endocrinol. 2018;6(7):547\u201354. https:\/\/doi.org\/10.1016\/s2213-8587(18)30100-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"952_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41440-021-00706-1","volume":"44","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Rakugi H. Angiotensin receptor-neprilysin inhibitors: comprehensive review and implications in hypertension treatment. Hypertens Res. 2021;44(10):1239\u201350. https:\/\/doi.org\/10.1038\/s41440-021-00706-1.","journal-title":"Hypertens Res"},{"issue":"4","key":"952_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11897-020-00463-1","volume":"17","author":"G Tersalvi","year":"2020","unstructured":"Tersalvi G, Dauw J, Martens P, Mullens W. Impact of sacubitril-valsartan on markers of glomerular function. Curr Heart Fail Rep. 2020;17(4):145\u201352. https:\/\/doi.org\/10.1007\/s11897-020-00463-1.","journal-title":"Curr Heart Fail Rep"},{"issue":"8","key":"952_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589\u2013600. https:\/\/doi.org\/10.1056\/NEJMra020528.","journal-title":"N Engl J Med"},{"issue":"1","key":"952_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13730-020-00504-7","volume":"10","author":"M Morimoto","year":"2021","unstructured":"Morimoto M, Arai T, Matsuura M, Ono Y. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer. CEN Case Rep. 2021;10(1):6\u201311. https:\/\/doi.org\/10.1007\/s13730-020-00504-7.","journal-title":"CEN Case Rep"},{"issue":"5","key":"952_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41379-018-0186-4","volume":"32","author":"F Person","year":"2019","unstructured":"Person F, Rinschen MM, Brix SR, Wulf S, Noriega MLM, Fehrle W, et al. Bevacizumab-associated glomerular microangiopathy. Mod Pathol. 2019;32(5):684\u2013700. https:\/\/doi.org\/10.1038\/s41379-018-0186-4.","journal-title":"Mod Pathol"},{"issue":"5","key":"952_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/jci17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649\u201358. https:\/\/doi.org\/10.1172\/jci17189.","journal-title":"J Clin Invest"},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"6051083","DOI":"10.1155\/2018\/6051083","volume":"2018","author":"MH Uriarte","year":"2018","unstructured":"Uriarte MH, Larrarte C, Rey LB. Scleroderma renal crisis debute with thrombotic microangiopathy: a successful case treated with eculizumab. Case Rep Nephrol. 2018;2018:6051083. https:\/\/doi.org\/10.1155\/2018\/6051083.","journal-title":"Case Rep Nephrol"},{"issue":"4","key":"952_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jash.2015.12.007","volume":"10","author":"RO Mathew","year":"2016","unstructured":"Mathew RO, Nayer A, Asif A. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. J Am Soc Hypertens. 2016;10(4):352\u20139. https:\/\/doi.org\/10.1016\/j.jash.2015.12.007.","journal-title":"J Am Soc Hypertens"},{"issue":"12","key":"952_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11906-016-0694-x","volume":"18","author":"E Uijl","year":"2016","unstructured":"Uijl E, Roksnoer LC, Hoorn EJ, Danser AH. From ARB to ARNI in cardiovascular control. Curr Hypertens Rep. 2016;18(12):86. https:\/\/doi.org\/10.1007\/s11906-016-0694-x.","journal-title":"Curr Hypertens Rep"},{"issue":"Suppl 1","key":"952_CR17","doi-asserted-by":"publisher","first-page":"P73","DOI":"10.1186\/2050-6511-14-S1-P73","volume":"14","author":"T Tokudome","year":"2013","unstructured":"Tokudome T, Otani K, Kishimoto I, Mao Y, Nakao K, Kangawa K. Endothelial GC-A can be a therapeutic target for metabolic syndrome. BMC Pharmacol Toxicol. 2013;14(Suppl 1):P73. https:\/\/doi.org\/10.1186\/2050-6511-14-S1-P73.","journal-title":"BMC Pharmacol Toxicol"},{"key":"952_CR18","doi-asserted-by":"publisher","first-page":"46624","DOI":"10.1038\/srep46624","volume":"7","author":"Y Kato","year":"2017","unstructured":"Kato Y, Mori K, Kasahara M, Osaki K, Ishii A, Mori KP, et al. Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition. Sci Rep. 2017;7:46624. https:\/\/doi.org\/10.1038\/srep46624.","journal-title":"Sci Rep"},{"issue":"2","key":"952_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1152\/physrev.00022.2015","volume":"96","author":"M Kuhn","year":"2016","unstructured":"Kuhn M. Molecular Physiology of Membrane Guanylyl Cyclase Receptors. Physiol Rev. 2016;96(2):751\u2013804. https:\/\/doi.org\/10.1152\/physrev.00022.2015.","journal-title":"Physiol Rev"},{"issue":"10","key":"952_CR20","doi-asserted-by":"publisher","first-page":"F1047","DOI":"10.1152\/ajprenal.00164.2014","volume":"308","author":"F Theilig","year":"2015","unstructured":"Theilig F, Wu Q. ANP-induced signaling cascade and its implications in renal pathophysiology. Am J Physiol Renal Physiol. 2015;308(10):F1047\u201355. https:\/\/doi.org\/10.1152\/ajprenal.00164.2014.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"952_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1476-5381.2012.01827.x","volume":"166","author":"M Kuhn","year":"2012","unstructured":"Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol. 2012;166(2):522\u201331. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01827.x.","journal-title":"Br J Pharmacol"},{"key":"952_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170352","volume":"132","author":"J Kato","year":"2020","unstructured":"Kato J. Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage. Peptides. 2020;132: 170352. https:\/\/doi.org\/10.1016\/j.peptides.2020.170352.","journal-title":"Peptides"},{"key":"952_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040798","author":"S Rubattu","year":"2019","unstructured":"Rubattu S, Forte M, Marchitti S, Volpe M. Molecular implications of natriuretic peptides in the protection from hypertension and target organ damage development. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20040798.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"952_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120362","volume":"10","author":"M Romero","year":"2015","unstructured":"Romero M, Caniffi C, Bouchet G, Costa MA, Elesgaray R, Arranz C, et al. Chronic treatment with atrial natriuretic peptide in spontaneously hypertensive rats: beneficial renal effects and sex differences. PLoS One. 2015;10(3): e0120362. https:\/\/doi.org\/10.1371\/journal.pone.0120362.","journal-title":"PLoS One"},{"issue":"10","key":"952_CR25","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1161\/atvbaha.109.187526","volume":"29","author":"T Tokudome","year":"2009","unstructured":"Tokudome T, Kishimoto I, Yamahara K, Osaki T, Minamino N, Horio T, et al. Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. Arterioscler Thromb Vasc Biol. 2009;29(10):1516\u201321. https:\/\/doi.org\/10.1161\/atvbaha.109.187526.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"952_CR26","doi-asserted-by":"publisher","first-page":"8684","DOI":"10.21037\/apm-21-157","volume":"10","author":"F Chen","year":"2021","unstructured":"Chen F, Tian G, Bai X, Li J, Yuan Z. The effect of Sacubitril\/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction. Ann Palliat Med. 2021;10(8):8684\u201391. https:\/\/doi.org\/10.21037\/apm-21-157.","journal-title":"Ann Palliat Med"},{"issue":"2","key":"952_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.17305\/bjbms.2017.1319","volume":"17","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Wang L, He S, Wang X, Shi W. Nitric oxide synthesis-promoting effects of valsartan in human umbilical vein endothelial cells via the Akt\/adenosine monophosphate-activated protein kinase\/endothelial nitric oxide synthase pathway. Bosn J Basic Med Sci. 2017;17(2):132\u20137. https:\/\/doi.org\/10.17305\/bjbms.2017.1319.","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"952_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1179\/1743132814y.0000000408","volume":"37","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Sano T, Umeda Y, Yamamoto A, Toma N, Sakaida H, et al. Valsartan prevents neointimal hyperplasia after carotid artery stenting by suppressing endothelial cell injuries. Neurol Res. 2015;37(1):35\u201342. https:\/\/doi.org\/10.1179\/1743132814y.0000000408.","journal-title":"Neurol Res"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00952-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00952-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00952-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:02:57Z","timestamp":1753916577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00952-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00952-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}